Sampayan, Wenielyn B.

HRN: 23-22-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2023
CEFUROXIME 500MG (TAB)
07/10/2023
07/17/2023
PO
500mg
BID
RMLE+repair, Thinly MSAF
Waiting Final Action 

Indication:  ProphylaxisEmpirical De-escalation    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: